Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine?

Fertil Steril. 2012 May;97(5):1101-7. doi: 10.1016/j.fertnstert.2012.01.127. Epub 2012 Feb 22.

Abstract

Objective: To update results on outcomes with frozen/thawed oocytes using a differential sucrose concentration during dehydration (0.2 M) and rehydration (0.3 M), combined with a one-step propanediol exposure.

Design: Retrospective cohort study.

Setting: Private IVF centers.

Patient(s): Infertile couples undergoing IVF treatment.

Intervention(s): Oocyte thawing cycles between May 2004 and December 2010.

Main outcome measure(s): Survival, fertilization, and cleavage rates were reported to evaluate biological outcomes. Clinical pregnancy and implantation rates were analyzed as markers of efficiency.

Result(s): Three hundred forty-two patients and 443 cycles were monitored; the survival was 71.8%, fertilization 77.9%, and of the embryos obtained 83.8% were classified as grade 1 and 2. Three hundred ninety-four transfers were performed, resulting in 90 pregnancies. The pregnancy rate per transfer was 22.8% and per patient was 26.3%, with 122 gestational sacs. The implantation rate per embryo was 13.5%. Patients were divided into three groups according to their age: ≤ 34 years (group A), 35-38 years (group B), and ≥ 39 years (group C). Biological outcomes were comparable in all three groups, whereas the pregnancy rate per transfer was higher in the first group (27.7% vs. 21.4% and 17.6%). The implantation rates per injected egg were 11.8%, 8.0%, and 7.5% for the three groups, respectively.

Conclusion(s): The biological and clinical data obtained on 443 cycles are consistent with our previous results showing that slow freezing of oocytes can be a valid tool in IVF practice when performed with a suitable protocol.

MeSH terms

  • Adult
  • Cell Survival / drug effects
  • Chi-Square Distribution
  • Cleavage Stage, Ovum
  • Cryopreservation / methods*
  • Cryoprotective Agents / pharmacology*
  • Embryo Implantation
  • Embryo Transfer
  • Female
  • Fertilization in Vitro
  • Humans
  • Infertility / physiopathology
  • Infertility / therapy*
  • Italy
  • Oocyte Retrieval*
  • Oocytes / drug effects*
  • Oocytes / pathology
  • Pregnancy
  • Pregnancy Rate
  • Propylene Glycols / pharmacology
  • Retrospective Studies
  • Sucrose / pharmacology*
  • Time Factors
  • Treatment Outcome

Substances

  • Cryoprotective Agents
  • Propylene Glycols
  • Sucrose